Journal of Pharmaceutical and Biomedical Analysis · 2018 · 20 citations · 17 references
MedicineOncologyPharmacologyChemotherapyMetabolomicsMolecular OncologyCancer MetabolomicsClinical MetabolomicsLung Cancer PharmacotherapyMass Spectrometry-based MetabolomicsMetabolite ProfilingMetabolomics Data AnalysisCancer Drug Response PredictionChemometrics In MetabolomicsMetabolic Signature DiscoveryMetabolomic Tumor MarkersMetabolomics-based Toxicity AssessmentQuantitative MetabolomicsTherapeutic Response Metabolomics
17
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Otto Warbürg · Science · 1956 · 13.3K citations
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2009 · 4.1K citations · Full text
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle, Janeta Popovici-Müller, Nicolaos Palaskas et al. · Science · 2013 · 1.2K citations
Medicine, Cancer Biology, Oncology +17
Horst Bickel, J. W. Gerrard, EvelynM. Hickmans · The Lancet · 1953 · 495 citations